BGN Technologies, the technology transfer company for Ben-Gurion University of the Negev (BGU), has signed a licensing agreement for its V-Smart drug delivery technology with Lauren Sciences LLC, a privately held biotechnology company in New York. Lauren Sciences will develop the technology as a platform for treating a variety of diseases that affect the central nervous system, including Parkinson’s, Alzheimer’s and Amyotrophic Lateral Sclerosis (ALS). The V-Smart technology pinpoints where the drug will be released in the brain, to increase efficacy and reduce adverse effects.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
New Program Supporting Early-Stage Construction Startups In North
October 13, 2024
IAI Launches First US Innovation Center, New Accelerator Program
October 13, 2024
Israeli Cybersecurity Startup To Provide Training For IDF
October 10, 2024
Johnson & Johnson Completes Purchase Of Israeli Startup V-Wave
October 10, 2024
Facebook comments